159 related articles for article (PubMed ID: 16426044)
1. Topological descriptors in modeling the antimalarial activity of 4-(3',5'-disubstituted anilino)quinolines.
Gupta MK; Prabhakar YS
J Chem Inf Model; 2006; 46(1):93-102. PubMed ID: 16426044
[TBL] [Abstract][Full Text] [Related]
2. CP-MLR directed QSAR studies on the antimycobacterial activity of functionalized alkenols--topological descriptors in modeling the activity.
Gupta MK; Sagar R; Shaw AK; Prabhakar YS
Bioorg Med Chem; 2005 Jan; 13(2):343-51. PubMed ID: 15598557
[TBL] [Abstract][Full Text] [Related]
3. QSAR study about ATP-sensitive potassium channel activation of cromakalim analogues using CP-MLR approach.
Sharma S; Prabhakar YS; Singh P; Sharma BK
Eur J Med Chem; 2008 Nov; 43(11):2354-60. PubMed ID: 18353509
[TBL] [Abstract][Full Text] [Related]
4. Topological descriptors in modeling the agonistic activity of human A3 adenosine receptor ligands: the derivatives of 2-chloro-N(6)-substituted-4'-thioadenosine-5'-uronamide.
Sharma S; Sharma BK; Sharma SK; Singh P; Prabhakar YS
Eur J Med Chem; 2009 Apr; 44(4):1377-82. PubMed ID: 18973967
[TBL] [Abstract][Full Text] [Related]
5. A high dimensional QSAR study on the aldose reductase inhibitory activity of some flavones: topological descriptors in modeling the activity.
Prabhakar YS; Gupta MK; Roy N; Venkateswarlu Y
J Chem Inf Model; 2006; 46(1):86-92. PubMed ID: 16426043
[TBL] [Abstract][Full Text] [Related]
6. Molecular electronic properties of a series of 4-quinolinecarbinolamines define antimalarial activity profile.
Bhattacharjee AK; Karle JM
J Med Chem; 1996 Nov; 39(23):4622-9. PubMed ID: 8917651
[TBL] [Abstract][Full Text] [Related]
7. Antimalarial activity: a QSAR modeling using CODESSA PRO software.
Katritzky AR; Kulshyn OV; Stoyanova-Slavova I; Dobchev DA; Kuanar M; Fara DC; Karelson M
Bioorg Med Chem; 2006 Apr; 14(7):2333-57. PubMed ID: 16426851
[TBL] [Abstract][Full Text] [Related]
8. Quinolines and structurally related heterocycles as antimalarials.
Kaur K; Jain M; Reddy RP; Jain R
Eur J Med Chem; 2010 Aug; 45(8):3245-64. PubMed ID: 20466465
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antimalarial activity of carbamate and amide derivatives of 4-anilinoquinoline.
Delarue-Cochin S; Grellier P; Maes L; Mouray E; Sergheraert C; Melnyk P
Eur J Med Chem; 2008 Oct; 43(10):2045-55. PubMed ID: 18226428
[TBL] [Abstract][Full Text] [Related]
10. Similar structure-activity relationships of quinoline derivatives for antiprion and antimalarial effects.
Klingenstein R; Melnyk P; Leliveld SR; Ryckebusch A; Korth C
J Med Chem; 2006 Aug; 49(17):5300-8. PubMed ID: 16913719
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, cytotoxic activity, DNA topoisomerase-II inhibition, molecular modeling and structure-activity relationship of 9-anilinothiazolo[5,4-b]quinoline derivatives.
Loza-Mejía MA; Olvera-Vázquez S; Maldonado-Hernández K; Guadarrama-Salgado T; González-Sánchez I; Rodríguez-Hernández F; Solano JD; Rodríguez-Sotres R; Lira-Rocha A
Bioorg Med Chem; 2009 May; 17(9):3266-77. PubMed ID: 19364657
[TBL] [Abstract][Full Text] [Related]
12. QSAR study on tetrahydroquinoline analogues as plasmodium protein farnesyltransferase inhibitors: a comparison of rationales of malarial and mammalian enzyme inhibitory activities for selectivity.
Gupta MK; Prabhakar YS
Eur J Med Chem; 2008 Dec; 43(12):2751-67. PubMed ID: 18329140
[TBL] [Abstract][Full Text] [Related]
13. Docking studies and development of novel 5-heteroarylamino-2,4-diamino-8-chloropyrimido-[4,5-b]quinolines as potential antimalarials.
Joshi AA; Viswanathan CL
Bioorg Med Chem Lett; 2006 May; 16(10):2613-7. PubMed ID: 16516468
[TBL] [Abstract][Full Text] [Related]
14. Exploration of rate-limiting conformational state for 5-[(7-chloro-4-quinolinyl)amino]-3-[(alkylamino)methyl][1,1'-biphenyl]-2-ols and N(omega)-oxides (tebuquine analogues) for antimalarial activity using molecular shape analysis and molecular field analysis studies.
Sharma P; Chhabra S; Rai N; Ghoshal N
J Chem Inf Model; 2007; 47(3):1087-96. PubMed ID: 17425301
[TBL] [Abstract][Full Text] [Related]
15. UV photoelectron spectroscopic study of substituent effects in quinoline derivatives.
Novak I; Kovac B
J Org Chem; 2004 Jul; 69(15):5005-10. PubMed ID: 15255728
[TBL] [Abstract][Full Text] [Related]
16. QSAR studies on 4-anilino-3-quinolinecarbonitriles as Src kinase inhibitors using robust PCA and both linear and nonlinear models.
Sun M; Zheng Y; Wei H; Chen J; Ji M
J Enzyme Inhib Med Chem; 2009 Oct; 24(5):1109-16. PubMed ID: 19555174
[TBL] [Abstract][Full Text] [Related]
17. Pd-catalyzed imine cyclization: synthesis of antimalarial natural products Aplidiopsamine A, Marinoquinoline A, and their potential hybrid NCLite-M1.
Mahajan JP; Suryawanshi YR; Mhaske SB
Org Lett; 2012 Nov; 14(22):5804-7. PubMed ID: 23094598
[TBL] [Abstract][Full Text] [Related]
18. Quantitative structure-activity relationship studies of antimalarial compounds from their calculated mathematical descriptors.
Basak SC; Mills D; Hawkins DM; Bhattacharjee AK
SAR QSAR Environ Res; 2010 Jan; 21(1):103-25. PubMed ID: 20373216
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antiproliferative evaluation of certain 4-anilino-8-methoxy-2-phenylquinoline and 4-anilino-8-hydroxy-2-phenylquinoline derivatives.
Chen YL; Huang CJ; Huang ZY; Tseng CH; Chang FS; Yang SH; Lin SR; Tzeng CC
Bioorg Med Chem; 2006 May; 14(9):3098-105. PubMed ID: 16412647
[TBL] [Abstract][Full Text] [Related]
20. CP-MLR/PLS directed QSAR study on the glutaminyl cyclase inhibitory activity of imidazoles: rationales to advance the understanding of activity profile.
Kumar V; Gupta MK; Singh G; Prabhakar YS
J Enzyme Inhib Med Chem; 2013 Jun; 28(3):515-22. PubMed ID: 22304474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
